Live news related to CELYAD ONCOLOGY stock (BE0974260896): press releases, earnings publications, share price moves, analyst notes and corporate events. This page is auto-updated whenever new financial information is available.
The latest financial news on CELYAD ONCOLOGY mainly cover M&A activity. The stock trades at €0,29 on Euronext Paris, up 9,47% at the last update. This page lists the articles published on CELYAD ONCOLOGY stock to track the share price, company announcements and any item likely to influence market perception.
Belgian biotechnology firm Celyad Oncology has completed a capital increase with Fortress Investment Group for €500,000, enabling the latter to become…
